Financials
- Market Capitalization 156.73 M
- Employee 29
- Founded 2015
- CEO N/A
- Website nrxpharma.com
- Headquarter Delaware, United States
- FIGI BBG00JCWDN63
- Industry Biotechnology
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 3722 | IFRX InflaRx N.V. - Common Stock | 2.28 USD | +0.44% | +11.22% | +34.91% | +65.22% | 164.83 M USD | ||
| 3736 | TNYA Tenaya Therapeutics, Inc. - Common Stock | 0.70 USD | 0.00% | +1.45% | -6.67% | -39.13% | 156.96 M USD | ||
| 3741 | OTLK Outlook Therapeutics, Inc. - Common Stock | 0.64 USD | +3.23% | -7.25% | -28.09% | +55.15% | 155.81 M USD | ||
| 3742 | EQ Equillium, Inc. - Common Stock | 2.42 USD | -1.22% | +5.68% | +6.61% | +34.44% | 153.45 M USD |
Frequently asked questions about NRX Pharmaceuticals, Inc. Common Stock
What is the NRX Pharmaceuticals, Inc. Common Stock stock price today?
The current price of NRX Pharmaceuticals, Inc. Common Stock (NRXP) is 3.62. Over the past 24 hours, the stock has changed by +4.62%. Follow the NRXP chart for real-time price dynamics.
What is the stock ticker of NRX Pharmaceuticals, Inc. Common Stock?
NRX Pharmaceuticals, Inc. Common Stock trades under the ticker NRXP. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is NRX Pharmaceuticals, Inc. Common Stock stock going up?
NRXP has changed by +2.84% over the last week, +4.02% over the last month, and +103.37% over the last year. Review the chart to see whether the current move is part of a broader trend.
What is the market capitalization of NRX Pharmaceuticals, Inc. Common Stock?
NRX Pharmaceuticals, Inc. Common Stock currently has a market capitalization of 156.73 M. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.
What were NRX Pharmaceuticals, Inc. Common Stock earnings last quarter?
Last quarter, NRX Pharmaceuticals, Inc. Common Stock reported earnings of -0.44 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.
What was NRX Pharmaceuticals, Inc. Common Stock revenue for the last quarter?
NRX Pharmaceuticals, Inc. Common Stock reported quarterly revenue of 1.1 M. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.
What was NRX Pharmaceuticals, Inc. Common Stock net income for the last quarter?
NRX Pharmaceuticals, Inc. Common Stock reported net income of -16.52 M for the last quarter. The previous quarter showed -1.43 M, which means net income changed by -1055.24%.
How many employees does NRX Pharmaceuticals, Inc. Common Stock have?
As of the latest available data, NRX Pharmaceuticals, Inc. Common Stock has 29 employees. Workforce size can provide additional context about the company's scale and operations.
What is NRX Pharmaceuticals, Inc. Common Stock EBITDA?
NRX Pharmaceuticals, Inc. Common Stock EBITDA is -6.43 M, and its EBITDA margin is -584.38%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy NRX Pharmaceuticals, Inc. Common Stock stock?
You can buy NRX Pharmaceuticals, Inc. Common Stock (NRXP) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in NRX Pharmaceuticals, Inc. Common Stock stock?
Investing in NRX Pharmaceuticals, Inc. Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the NRXP chart and related analysis on metatrader.com as part of your research.